risks of glp 1 agonists Managing Side Effects GLP-1 Receptor – Transformation Weight Control GLP-1 Drugs and Eating Disorders:

After liraglutide 24 h urine sodium excretion increased in both groups vs

doi: 10.1016/j.mce.2020.110792 186 QinYLiTZhaoHMaoZDingCKangY

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T (2017) Exenatide once weekly versus placebo in Parkinsons disease: a randomised, double-blind, placebo-controlled trial

Cardiometabolic parameters during GLP-1 RA treatment GLP-1 RAs have also demonstrated important cardioprotective benefits that extend beyond their impact on BW loss